 |
|
A Neuroendocrine Study of Supersensitivity in Tardive Dyskinesia
Carol A. Tamminga, MD;
Robert C. Smith, MD, PhD;
Ghanshyam Pandey, PhD;
Lawrence A. Frohman, MD;
John M. Davis, MD
Arch Gen Psychiatry. 1977;34(10):1199-1203.
Abstract
• A study of the tuberoinfundibular dopamine tract was undertaken in chronic schizophrenic patients with and without tardive dyskinesia. Biochemical evidence of the purported dopamine receptor supersensitivity in tardive dyskinesia was sought by demonstrating a hyperresponse of growth hormone and prolactin to dopamine agonists. Contrary to this prediction, no endocrine supersensitivity occurred in the tardive dyskinesia patients. Rather, a significantly decreased response to dopaminergic stimualtion was demonstrated in the total chronic schizophrenic group.
Author Affiliations
From the Illinois State Psychiatric Institute (Drs Tamminga, Smith, Pandey, and Davis), the Division of Endocrinology and Metabolism, Michael Reese Hospital (Dr Frohman), and the Departments of Psychiatry (Drs Tamminga, Smith, and Davis) and Medicine (Dr Frohman), University of Chicago, Chicago. Dr Smith is now with the Texas Research Institute of Mental Sciences, Houston.
Footnotes
Accepted for publication May 6, 1977.
Read before the annual meeting of the Society for Neuroscience, Toronto, Nov, 1976.
Reprint requests to Department of Psychiatry, University of Chicago, 950 E 59th St, Chicago, IL 60637 (Dr Tamminga).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Brain Morphology, Dopamine, and Eye-Tracking Abnormalities in First-Episode Schizophrenia: Prevalence and Clinical Correlates
Lieberman et al.
Arch Gen Psychiatry 1993;50:357-368.
ABSTRACT
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman et al.
Arch Gen Psychiatry 1993;50:369-376.
ABSTRACT
Brain {gamma}-Aminobutyric Acid Abnormality in Tardive Dyskinesia: Reduction in Cerebrospinal Fluid GABA Levels and Therapeutic Response to GABA Agonist Treatment
Thaker et al.
Arch Gen Psychiatry 1987;44:522-529.
ABSTRACT
Evaluating Prolactin Response to Dopamine Agonists in Schizophrenia: Methodological Problems
Davis et al.
Arch Gen Psychiatry 1985;42:259-264.
ABSTRACT
Prostaglandins, Platelets, and Schizophrenia
Rotrosen et al.
Arch Gen Psychiatry 1980;37:1047-1054.
ABSTRACT
Psychiatry
Freedman
JAMA 1978;239:510-512.
|
